ЕР 0 606 046 A1, 13.07.1994. WO 96/00214 A1, 04.01.1996. Mark Whittaker et al.: "Design and Therapeutic Application of matrix metalloproteinase inhibitors", Chem. Rev., том 99, 1999, стр.2735-2776. Scozzafava A. et al: "Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporatingN-4-nitrobenzylsulfonylglycine hydroxamate moieties", Journal of Medicinal Chemistry, American Chemical Society, Washington, US, том 43, 9, 04.07.2000, с.1858-1865. ЕР 0935963 А2, 18.08.1999. WO 98/50348 A1, 12.11.1998. Dalip Kumar et al: "A quantitative structure-activity relationship study on some matrix metalloproteinase and collagenase inhibitors", Bioorganic & Medicinal Chemistry, том 11, 2003, с.421-426. WO 99/06340 А2, 11.02.1999. Scozzafava, Andrea et al: "Carbonac Anhydrase and Matrix Metalloproteinase Inhibitors: Sulfonylated Amino Acid Hydroxamates with MMP Inhibitory Properties Act as Efficient Inhibitors of CA Isozymes I, II, and IV, and N-Hydroxysulfonamides Inhibit Both These Zinc Enzymes", Journal of Medicinal Chemistry, том 43, 20, 2000, с.3677-3687. WO 98/33768 A1, 06.08.1998. WO 98/17645 A1, 30.04.1998. RU 2202540 C2, 20.04.2003.
Поиск патентов
Получить полное описание патента